OTC Pharmaceuticals in Asia-Pacific

OTC Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Scope

Essential resource for top-line data and analysis covering the Asia-Pacific otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons to buy

_x005F What was the size of the Asia-Pacific otc pharmaceuticals market by value in 2015

_x005F What will be the size of the Asia-Pacific otc pharmaceuticals market in 2020

_x005F What factors are affecting the strength of competition in the Asia-Pacific otc pharmaceuticals market

_x005F How has the market performed over the last five years

_x005F Who are the top competitors in Asia-Pacific's otc pharmaceuticals market

Companies mentioned

Bayer AG

GlaxoSmithKline Plc

Johnson & Johnson

Nin Jiom Medicines Manufactory Ltd

Table of Contents

Executive Summary

Market value

Market value forecast

Category segmentation

Geography segmentation

Market share

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Category segmentation

Geography segmentation

Market share

Market distribution

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

Bayer AG

GlaxoSmithKline Plc

Johnson & Johnson

Nin Jiom Medicines Manufactory Ltd

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine

List of Tables

Table 1: Asia-Pacific OTC pharmaceuticals market value: $ million, 201115

Table 2: AsiaPacific OTC pharmaceuticals market category segmentation: $ million, 2015

Table 3: AsiaPacific OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 4: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2015

Table 5: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2015

Table 6: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 201520

Table 7: Bayer AG: key facts

Table 8: Bayer AG: key financials ($)

Table 9: Bayer AG: key financials (€)

Table 10: Bayer AG: key financial ratios

Table 11: GlaxoSmithKline Plc: key facts

Table 12: GlaxoSmithKline Plc: key financials ($)

Table 13: GlaxoSmithKline Plc: key financials (£)

Table 14: GlaxoSmithKline Plc: key financial ratios

Table 15: Johnson & Johnson: key facts

Table 16: Johnson & Johnson: key financials ($)

Table 17: Johnson & Johnson: key financial ratios

Table 18: Nin Jiom Medicines Manufactory Ltd: key facts

List of Figures

Figure 1: Asia-Pacific OTC pharmaceuticals market value: $ million, 201115

Figure 2: AsiaPacific OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 3: AsiaPacific OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 4: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2015

Figure 5: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 6: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 201520

Figure 7: Forces driving competition in the OTC pharmaceuticals market in Asia-Pacific, 2015

Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Asia-Pacific, 2015

Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Asia-Pacific, 2015

Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Asia-Pacific, 2015

Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Asia-Pacific, 2015

Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Asia-Pacific, 2015

Figure 13: Bayer AG: revenues & profitability

Figure 14: Bayer AG: assets & liabilities

Figure 15: GlaxoSmithKline Plc: revenues & profitability

Figure 16: GlaxoSmithKline Plc: assets & liabilities

Figure 17: Johnson & Johnson: revenues & profitability

Figure 18: Johnson & Johnson: assets & liabilities

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports